07:17 AM EDT, 10/28/2024 (MT Newswires) -- Uranium Royalty ( UROY ) said Monday that it acquired an existing royalty on the Millennium and Cree Extension uranium projects in Saskatchewan for $6 million. The company said the royalty is a net profit interest of 10% on an approximate 21% stake in the projects, which are operated by Cameco ( CCJ...

07:48 AM EDT, 10/28/2024 (MT Newswires) -- Evoke Pharma ( EVOK ) shares surged more than 130% pre-bell Monday after the company reported results from a real-world study showing significant statistical improvement for its diabetic gastroparesis nasal therapy over oral metoclopramide. Monte Rosa Therapeutics ( GLUE ) shares advanced 42% after the company said it secured a global license deal...

07:51 AM EDT, 10/28/2024 (MT Newswires) -- Acadia Realty Trust ( AKR ) reported Q3 funds from operations Monday of $0.28 per share, up from $0.26 a year earlier. Analysts polled by Capital IQ expected $0.31. Revenue for the quarter ended Sept. 30 was $87.7 million, compared with $81.4 million a year earlier. Three analysts surveyed by Capital IQ expected...

07:47 AM EDT, 10/28/2024 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said Monday that it has entered into a global development and commercialization license agreement with Novartis ( NVS ) for VAV1-directed molecular glue degraders, including MRT-6160. The agreement gives Novartis ( NVS ) exclusive global rights to develop, manufacture, and commercialize MRT-6160 and other VAV1 MGDs, Monte...